Almost everyone asks whether they will have to take this forever. The trial data gives a clearer answer than most medical questions get.
The withdrawal trial
SURMOUNT-4 was designed specifically to answer this. Every participant took tirzepatide openly for 36 weeks and lost a mean of 20.9 percent of body weight. They were then randomised: half continued the drug, half switched to placebo, for another 52 weeks.
Over that year:
- The group that continued lost a further 5.5 percent
- The group switched to placebo regained 14.0 percent
By the end, total weight reduction from baseline was 25.3 percent for those who continued against 9.9 percent for those who stopped.
The maintenance figures are starker still. Of those who kept taking it, 89.5 percent held onto at least 80 percent of their weight loss. Among those who stopped, 16.6 percent did.
What this means
Obesity behaves like a chronic condition, and these medications treat it like one. The biology they alter reverts when the drug is withdrawn. Hunger returns, gastric emptying speeds back up, and weight follows.
This is not a flaw in the drugs or a failure in the patient. Blood pressure rises again when antihypertensives stop, and nobody frames that as the patient's fault. Obesity is treated differently in public conversation, which is worth noticing when you read commentary about people regaining weight.
Why people stop anyway
Most people who stop do not choose to:
- Cost or lost coverage. A plan changes, a job changes, a program ends. This is the most common reason.
- Side effects that do not settle
- Supply problems
- Reaching a goal weight and assuming the job is done, which the data says it is not
- Pregnancy, where stopping is appropriate
Planning for it
You cannot control every reason, but you can plan around them:
- Ask before you start how long your coverage lasts. If a program has an end date, know it. The Medicare GLP-1 Bridge, for instance, runs only to the end of 2027.
- Build habits while the medication makes it easier. They will not hold your weight on their own, but starting from established routines beats starting from nothing.
- Protect muscle throughout. Lean mass lost during rapid weight loss is not automatically regained, and losing it lowers your metabolic rate for the long term.
- If you must stop, taper with your prescriber rather than abruptly, and get a plan for what follows.
- Know the alternatives. For some people this is exactly the point at which surgery becomes the right conversation, precisely because it does not stop working when a prescription lapses.
If you have already regained
Regaining weight after stopping is the expected physiological outcome, not evidence that you did something wrong. It is worth saying plainly, because a lot of people carry it as a personal failure. The community forums are full of people who have been through exactly this.
Sources and references
- JAMA: SURMOUNT-4: tirzepatide continuation versus withdrawal after 36 weeks jamanetwork.com
- National Library of Medicine: Tirzepatide maintenance of weight reduction pmc.ncbi.nlm.nih.gov
- CMS: Medicare GLP-1 Bridge programme cms.gov